Sandbox:khurram
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief:
Differentiating [disease name] from other diseases on the basis of [symptom 1], [symptom 2], and [symptom 3]
On the basis [symptom 1], [symptom 2], and [symptom 3], [disease name] must be differentiated from [disease 1], [disease 2], [disease 3], [disease 4], [disease 5], and [disease 6].
| Diseases | Clinical manifestations | Para-clinical findings | Gold standard | Additional findings | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Symptoms | Physical examination | ||||||||||||||||
| Lab Findings | Imaging | Histopathology | |||||||||||||||
| Symptom 1 | Symptom 2 | Symptom 3 | Skin necrosis | Physical exam 2 | Physical exam 3 | Platelet count | Bleeding time | PT | PTT | Peripheral blood smear | Imaging 1 | Imaging 2 | Imaging 3 | ||||
| Antithrombin deficiency | |||||||||||||||||
| Factor V Leiden mutation | |||||||||||||||||
| Protein C deficiency | |||||||||||||||||
| Protein S deficiency | |||||||||||||||||
| Prothrombin gene mutation | |||||||||||||||||
| von Willebrand disease | Ristocetin cofactor assay | ||||||||||||||||
| DIC | |||||||||||||||||
| Antiphospholipid antibody syndrome | |||||||||||||||||